Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Rezolve Ai outlined a strategic operating program targeting approximately $60 million in annualized cost savings and positive Adjusted EBITDA by the end of the first half of 2027. The company has already implemented cost reduction measures including lowered acquisition expenditure, marketing, and legal costs, alongside efforts to integrate acquisit…
Forward Industries announced a $25 million registered direct offering of common stock to institutional investors at $8.00 per share. The proceeds will be used to acquire additional Solana (SOL) tokens, expanding the Company's SOL treasury and increasing SOL per fully diluted share. This capital raise supports Forward's strategy to strengthen its So…
Top Wealth Group Holding Limited, listed on NASDAQ, issued a positive profit alert projecting at least a 100% increase in net profit for the 2026 fiscal year compared to 2025. Key growth drivers include extensive marketing, successful sales of premium wines, operational efficiencies, and strategic vertical integration of its caviar business. The co…
Slide Insurance Holdings, Inc., a specialty property insurer focusing on coastal and catastrophe-prone markets, announced an expansion of its homeowners insurance products across South Carolina. The company introduced new HO5, HO3, and HO6 policies aimed at higher-value homes and condos, offering expanded coverage, discounts, and competitive rates.…
Tempest Therapeutics, a clinical-stage biotech company focused on in vivo CAR-T therapies for cancer and autoimmune diseases, has appointed Nancy Freda-Smith, an experienced finance and audit executive, to its board of directors. She will serve as Chair of the Audit Committee. Her expertise in corporate governance, global finance, and risk manageme…
Fiverr International Ltd. released its 2025 Impact Report showcasing efforts to shape a responsible and inclusive future of work through AI-driven innovation, social initiatives, and environmental sustainability. Key achievements include significant community investments, enhanced marketplace governance, strong employee engagement, and substantial …
Annovis Bio has partnered with Weave Bio, an AI-driven regulatory platform, to streamline the preparation and submission process of the New Drug Application (NDA) for their investigational oral therapy buntanetap targeting Alzheimer's disease. This collaboration aims to have substantial NDA documentation ready before the pivotal Phase 3 trial top-l…
HUHUTECH International Group Inc. reported an 8.6% increase in total revenue to $10.67 million for the first half of 2026, driven by new operations in the U.S., Germany, and Singapore contributing $3.7 million. The company saw a strategic geographic expansion beyond China and Japan despite a planned Japanese revenue contraction. Net loss increased …
Altimmune, a late clinical-stage biopharmaceutical company developing therapies for serious liver diseases, announced its management will participate in a fireside chat at the Stifel 2026 Virtual Cardiometabolic Forum on September 30, 2026. The discussion will focus on their lead candidate pemvidutide, an investigational therapy targeting metabolic…
MeiraGTx Holdings plc announced the appointment of Alan M. Sebulsky, an experienced healthcare portfolio manager and biopharma investment analyst, to its Board of Directors. Mr. Sebulsky brings over 40 years of industry experience, including significant roles in biopharmaceutical portfolio management and board leadership, supporting MeiraGTx as it …
Hyperliquid (HYPX) is an early-stage decentralized exchange ecosystem that aims to combine concentrated liquidity, on-chain order routing, and native incentive layers. This trade idea argues for a speculative long entry at $0.75 with a $2.50 target and $0.40 stop based on the potential for platform-specific liquidity growth, token utility expansion…
BIO-key International announces its Passkey:YOU authentication solution has achieved Full Certification from the FIDO Alliance, validating its compliance with phishing-resistant passwordless authentication standards. This certification enables Passkey:YOU to integrate seamlessly with major identity platforms and supports biometric authentication wi…
Spire is a small-cap satellite-data provider trading at a modest market cap and high revenue multiple for a growth-to-profit pivot. If NOAA-related contracts or other government work accelerate in H2, revenue and backlog could re-rate the stock. This trade targets that inflection while keeping a tight stop to limit downside from execution risk.
Clearmind Medicine Inc., a clinical-stage biopharmaceutical company listed on Nasdaq, announced the publication of three U.S. patent applications for novel combinations of LSD, ketamine, and ibogaine with N-acylethanolamines, including PEA. These patents potentially cover therapeutic uses for depression, PTSD, pain, and substance use disorders, exp…
3 E Network Technology Group Limited announces that its Nordic subsidiary, Aurora Core Technology Oy, has entered the implementation phase for a multi-megawatt green energy AI data center project in Finland. The subsidiary is managing procurement, grid interconnection, environmental approvals, municipal waste heat monetization negotiations, local e…
SK hynix looks positioned to extend recent improvement as DRAM and NAND chips reflate on AI and server demand. This is a tactical long trade sized for a mid-term swing: entry at $95.00, a stop at $82.50, and a target at $120.00. The trade leans on clearer demand signals, expanding high-margin HBM exposure, and an overall memory cycle recovery while…
BridgeBio Pharma announced results from a peer-reviewed real-world study demonstrating that Acoramidis significantly reduces the risk of clinical worsening events in transthyretin amyloid cardiomyopathy (ATTR-CM) patients compared to Tafamidis. The study showed a 34% reduction in composite risk of worsening, including heart failure hospitalization …
Archer (ACHR) trades at $5.695 after a 62% drop from its 52-week high. Negative profitability, steep cash burn, and heavy short activity combine with uncertain certification and integration milestones to create a high-risk setup. We favor a tactical short over the next 45 trading days, with a clear entry, stop and target.
VEON Ltd., a global digital operator listed on NASDAQ, announced an increased share buyback program worth approximately $200 million to repurchase 3.9% of its outstanding shares. The company plans to cancel all repurchased shares, reinforcing its capital allocation discipline and commitment to long-term value creation. This program represents a sig…
Winnebago Industries announced it will release its fourth quarter and full fiscal 2026 financial results on October 21, 2026, before the NYSE opens. A conference call will follow, hosted by its CEO and CFO, accessible via the company's investor relations website. The company is a leading North American manufacturer of outdoor recreation products in…
Artelo Biosciences announced the filing of a new provisional patent application for ART27.13, a dual cannabinoid receptor agonist, targeting obesity treatment both as monotherapy and combined with GLP-1 receptor agonists like semaglutide. Nonclinical studies demonstrated up to 40% weight loss in obese mice when ART27.13 was combined with semaglutid…
Turning Point Brands (TPB) has been punished this year on FDA-related headlines and heavy marketing investments that temporarily compress earnings. The sell-off has pushed technicals into deeply oversold territory while balance-sheet metrics and cash flow remain intact. We upgrade TPB to a buy for a tactical swing trade - the market is now overly c…
Beneficient has announced a comprehensive strategy to eliminate the fraudulent HCLP debt of approximately $130 million and convert the former CEO Brad Heppner's substantial equity interests valued around $850 million into common stock, while terminating all related agreements. This follows Heppner's conviction for securities and wire fraud. The res…
Wave Life Sciences initiated a Phase 2a clinical trial evaluating its investigational RNA medicine WVE-007 in combination with tirzepatide for obesity treatment. Preclinical and emerging data indicate that WVE-007, utilizing GalNAc-siRNA technology, induces fat loss without muscle loss and could enhance weight loss beyond GLP-1 therapies alone. The…
TON Strategy Company is a leveraged, asymmetric play on the revival and market adoption of GRAM. For traders willing to accept high volatility and structural uncertainty, a modest long position around $1.20 with a tight stop and a $2.80 target offers a favorable risk-reward if token catalysts materialize over the next 45 trading days.
